Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Neoplasms 1 Thymoma 1 Thymic epithelial tumor 1 Ovarian Neoplasms 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 30 Radiotherapy 24 pembrolizumab 21 Cetuximab 21 Docetaxel 13 Fluorouracil 12 Radiotherapy, Intensity-Modulated 10 Paclitaxel 9 Radiation 8 Nivolumab 7 Everolimus 7 Carboplatin 7 Oxaliplatin 6 Gemcitabine 5 Surgical Procedures, Operative 4 Radiosurgery 4 Magnetic Resonance Spectroscopy 4 Gefitinib 4 Erlotinib Hydrochloride 4 Amifostine 4 Pemetrexed 3 Filgrastim 3 Capecitabine 3 Bleomycin 3 Biopsy 3 zalutumumab 2 spartalizumab 2 pegfilgrastim 2 niraparib 2 durvalumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Head and Neck Neoplasms × TP protocol × Clear all

NCT01126216 2021-05-04

Paccis-RCT

University of Erlangen-Nürnberg Medical School

Phase 3 Terminated

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡